{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "62960b77",
   "metadata": {},
   "source": [
    "# Disease Prediction based on symptoms using NLP"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "92491e1d",
   "metadata": {},
   "source": [
    "## Exploring Data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "f12760a0",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "from mpl_toolkits.mplot3d import Axes3D\n",
    "from sklearn.preprocessing import StandardScaler\n",
    "import seaborn as sns\n",
    "import matplotlib.pyplot as plt\n",
    "import numpy as np \n",
    "import os\n",
    "import pandas as pd \n",
    "import nltk\n",
    "import string"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "9b9d52d1",
   "metadata": {},
   "outputs": [],
   "source": [
    "# loading the training dataset\n",
    "training_data = pd.read_csv('dataset//drugsComTrain_raw.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "64fff915",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>uniqueID</th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>206461</td>\n",
       "      <td>Valsartan</td>\n",
       "      <td>Left Ventricular Dysfunction</td>\n",
       "      <td>\"It has no side effect, I take it in combinati...</td>\n",
       "      <td>9</td>\n",
       "      <td>May 20, 2012</td>\n",
       "      <td>27</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>95260</td>\n",
       "      <td>Guanfacine</td>\n",
       "      <td>ADHD</td>\n",
       "      <td>\"My son is halfway through his fourth week of ...</td>\n",
       "      <td>8</td>\n",
       "      <td>April 27, 2010</td>\n",
       "      <td>192</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>92703</td>\n",
       "      <td>Lybrel</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>\"I used to take another oral contraceptive, wh...</td>\n",
       "      <td>5</td>\n",
       "      <td>December 14, 2009</td>\n",
       "      <td>17</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>138000</td>\n",
       "      <td>Ortho Evra</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>\"This is my first time using any form of birth...</td>\n",
       "      <td>8</td>\n",
       "      <td>November 3, 2015</td>\n",
       "      <td>10</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>35696</td>\n",
       "      <td>Buprenorphine / naloxone</td>\n",
       "      <td>Opiate Dependence</td>\n",
       "      <td>\"Suboxone has completely turned my life around...</td>\n",
       "      <td>9</td>\n",
       "      <td>November 27, 2016</td>\n",
       "      <td>37</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   uniqueID                  drugName                     condition  \\\n",
       "0    206461                 Valsartan  Left Ventricular Dysfunction   \n",
       "1     95260                Guanfacine                          ADHD   \n",
       "2     92703                    Lybrel                 Birth Control   \n",
       "3    138000                Ortho Evra                 Birth Control   \n",
       "4     35696  Buprenorphine / naloxone             Opiate Dependence   \n",
       "\n",
       "                                              review  rating  \\\n",
       "0  \"It has no side effect, I take it in combinati...       9   \n",
       "1  \"My son is halfway through his fourth week of ...       8   \n",
       "2  \"I used to take another oral contraceptive, wh...       5   \n",
       "3  \"This is my first time using any form of birth...       8   \n",
       "4  \"Suboxone has completely turned my life around...       9   \n",
       "\n",
       "                date  usefulCount  \n",
       "0       May 20, 2012           27  \n",
       "1     April 27, 2010          192  \n",
       "2  December 14, 2009           17  \n",
       "3   November 3, 2015           10  \n",
       "4  November 27, 2016           37  "
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "training_data.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "4ad98675",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(161297, 7)"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# checking for shape\n",
    "training_data.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "8f21b476",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "uniqueID         0\n",
       "drugName         0\n",
       "condition      899\n",
       "review           0\n",
       "rating           0\n",
       "date             0\n",
       "usefulCount      0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# checking for missing values\n",
    "training_data.isna().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "dacd3c58",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "condition\n",
       "Birth Control                                              28788\n",
       "Depression                                                  9069\n",
       "Pain                                                        6145\n",
       "Anxiety                                                     5904\n",
       "Acne                                                        5588\n",
       "                                                           ...  \n",
       "Dissociative Identity Disorde                                  1\n",
       "Hydrocephalus                                                  1\n",
       "Hyperlipoproteinemia Type III, Elevated beta-VLDL   IDL        1\n",
       "Q Feve                                                         1\n",
       "Neutropenia                                                    1\n",
       "Name: count, Length: 884, dtype: int64"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# checking for the most common conditions\n",
    "training_data['condition'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "c94de521",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "condition\n",
       "Birth Control                                              0.179479\n",
       "Depression                                                 0.056541\n",
       "Pain                                                       0.038311\n",
       "Anxiety                                                    0.036808\n",
       "Acne                                                       0.034838\n",
       "                                                             ...   \n",
       "Dissociative Identity Disorde                              0.000006\n",
       "Hydrocephalus                                              0.000006\n",
       "Hyperlipoproteinemia Type III, Elevated beta-VLDL   IDL    0.000006\n",
       "Q Feve                                                     0.000006\n",
       "Neutropenia                                                0.000006\n",
       "Name: proportion, Length: 884, dtype: float64"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# checking for the most common conditions\n",
    "training_data['condition'].value_counts(normalize=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "18034385",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of Unique Drugs present in the Dataset :  3436\n",
      "Number of Unique Medical Conditions present in the Dataset :  884\n"
     ]
    }
   ],
   "source": [
    "# exploring unique elements in the dataset\n",
    "\n",
    "print(\"Number of Unique Drugs present in the Dataset : \", training_data['drugName'].nunique())\n",
    "print(\"Number of Unique Medical Conditions present in the Dataset : \", training_data['condition'].nunique())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "fe72d8a0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>count</th>\n",
       "      <td>161297</td>\n",
       "      <td>160398</td>\n",
       "      <td>161297</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>unique</th>\n",
       "      <td>3436</td>\n",
       "      <td>884</td>\n",
       "      <td>112329</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>top</th>\n",
       "      <td>Levonorgestrel</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>\"Good\"</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>freq</th>\n",
       "      <td>3657</td>\n",
       "      <td>28788</td>\n",
       "      <td>33</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "              drugName      condition  review\n",
       "count           161297         160398  161297\n",
       "unique            3436            884  112329\n",
       "top     Levonorgestrel  Birth Control  \"Good\"\n",
       "freq              3657          28788      33"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# summarizing Categorical Data\n",
    "training_data[['drugName','condition','review']].describe(include = 'object')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "c40f71e0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "uniqueID       0\n",
       "drugName       0\n",
       "condition      0\n",
       "review         0\n",
       "rating         0\n",
       "date           0\n",
       "usefulCount    0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# dropping the missing values of the conditions\n",
    "\n",
    "training_data = training_data.dropna()\n",
    "training_data.isna().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "7d8e4aef",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(160398, 7)"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# checking the new shape\n",
    "training_data.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "24e26173",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>uniqueID</th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>163740</td>\n",
       "      <td>Mirtazapine</td>\n",
       "      <td>Depression</td>\n",
       "      <td>\"I&amp;#039;ve tried a few antidepressants over th...</td>\n",
       "      <td>10</td>\n",
       "      <td>February 28, 2012</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>206473</td>\n",
       "      <td>Mesalamine</td>\n",
       "      <td>Crohn's Disease, Maintenance</td>\n",
       "      <td>\"My son has Crohn&amp;#039;s disease and has done ...</td>\n",
       "      <td>8</td>\n",
       "      <td>May 17, 2009</td>\n",
       "      <td>17</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>159672</td>\n",
       "      <td>Bactrim</td>\n",
       "      <td>Urinary Tract Infection</td>\n",
       "      <td>\"Quick reduction of symptoms\"</td>\n",
       "      <td>9</td>\n",
       "      <td>September 29, 2017</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>39293</td>\n",
       "      <td>Contrave</td>\n",
       "      <td>Weight Loss</td>\n",
       "      <td>\"Contrave combines drugs that were used for al...</td>\n",
       "      <td>9</td>\n",
       "      <td>March 5, 2017</td>\n",
       "      <td>35</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>97768</td>\n",
       "      <td>Cyclafem 1 / 35</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>\"I have been on this birth control for one cyc...</td>\n",
       "      <td>9</td>\n",
       "      <td>October 22, 2015</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   uniqueID         drugName                     condition  \\\n",
       "0    163740      Mirtazapine                    Depression   \n",
       "1    206473       Mesalamine  Crohn's Disease, Maintenance   \n",
       "2    159672          Bactrim       Urinary Tract Infection   \n",
       "3     39293         Contrave                   Weight Loss   \n",
       "4     97768  Cyclafem 1 / 35                 Birth Control   \n",
       "\n",
       "                                              review  rating  \\\n",
       "0  \"I&#039;ve tried a few antidepressants over th...      10   \n",
       "1  \"My son has Crohn&#039;s disease and has done ...       8   \n",
       "2                      \"Quick reduction of symptoms\"       9   \n",
       "3  \"Contrave combines drugs that were used for al...       9   \n",
       "4  \"I have been on this birth control for one cyc...       9   \n",
       "\n",
       "                 date  usefulCount  \n",
       "0   February 28, 2012           22  \n",
       "1        May 17, 2009           17  \n",
       "2  September 29, 2017            3  \n",
       "3       March 5, 2017           35  \n",
       "4    October 22, 2015            4  "
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# loading the test dataset\n",
    "\n",
    "test_data = pd.read_csv('dataset//drugsComTest_raw.csv')\n",
    "test_data.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "c2c765d7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(53766, 7)"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# checking for the shape\n",
    "test_data.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "882478fc",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "uniqueID         0\n",
       "drugName         0\n",
       "condition      295\n",
       "review           0\n",
       "rating           0\n",
       "date             0\n",
       "usefulCount      0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# checking for missing values\n",
    "test_data.isna().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "3b22470d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "uniqueID       0\n",
       "drugName       0\n",
       "condition      0\n",
       "review         0\n",
       "rating         0\n",
       "date           0\n",
       "usefulCount    0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# dropping the missing values for the condition column\n",
    "test_data = test_data.dropna()\n",
    "\n",
    "test_data.isna().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "6be3955b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of Unique Drugs present in the Dataset : 2635\n",
      "Number of Unique Medical Conditions present in the Dataset : 708\n"
     ]
    }
   ],
   "source": [
    "# exploring unique elements in the dataset\n",
    "\n",
    "print(\"Number of Unique Drugs present in the Dataset :\", test_data['drugName'].nunique())\n",
    "print(\"Number of Unique Medical Conditions present in the Dataset :\", test_data['condition'].nunique())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "378a5fe0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>count</th>\n",
       "      <td>53471</td>\n",
       "      <td>53471</td>\n",
       "      <td>53471</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>unique</th>\n",
       "      <td>2635</td>\n",
       "      <td>708</td>\n",
       "      <td>48051</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>top</th>\n",
       "      <td>Levonorgestrel</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>\"Good.\"</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>freq</th>\n",
       "      <td>1265</td>\n",
       "      <td>9648</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "              drugName      condition   review\n",
       "count            53471          53471    53471\n",
       "unique            2635            708    48051\n",
       "top     Levonorgestrel  Birth Control  \"Good.\"\n",
       "freq              1265           9648        8"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# summarizing Categorical Data\n",
    "test_data[['drugName','condition','review']].describe(include = 'object')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ec9e0b13",
   "metadata": {},
   "source": [
    "# Exploratory Data Anaylsis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "eda85cde",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x400 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import warnings\n",
    "warnings.filterwarnings(\"ignore\")\n",
    "\n",
    "plt.rcParams['figure.figsize'] = (10, 4)\n",
    "\n",
    "plt.subplot(1, 2, 1)\n",
    "sns.distplot(training_data['rating'])\n",
    "\n",
    "plt.subplot(1, 2, 2)\n",
    "sns.distplot(training_data['usefulCount'])\n",
    "\n",
    "plt.suptitle('Distribution of Rating and Useful Count \\n ', fontsize = 20)\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "5fb86793",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.rcParams['figure.figsize'] = (10, 4)\n",
    "sns.barplot(x = training_data['rating'], y = training_data['usefulCount'], palette = 'hot')\n",
    "plt.xlabel('\\n Ratings')\n",
    "plt.ylabel('Count\\n', fontsize = 20)\n",
    "plt.title('\\n Rating vs Usefulness \\n', fontsize = 20)\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "f95f34df",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0          79\n",
       "1         740\n",
       "2         754\n",
       "3         448\n",
       "4         719\n",
       "         ... \n",
       "161292    689\n",
       "161293    262\n",
       "161294     95\n",
       "161295    771\n",
       "161296    347\n",
       "Name: len, Length: 160398, dtype: int64"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Checking whether Length of Review has any Impact on Ratings of the Drugs\n",
    "# for that we need to create a new column to calculate length of the reviews\n",
    "\n",
    "training_data['len']  = training_data['review'].apply(len)\n",
    "training_data['len']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "cddc9726",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead tr th {\n",
       "        text-align: left;\n",
       "    }\n",
       "\n",
       "    .dataframe thead tr:last-of-type th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr>\n",
       "      <th></th>\n",
       "      <th colspan=\"3\" halign=\"left\">len</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th></th>\n",
       "      <th>min</th>\n",
       "      <th>mean</th>\n",
       "      <th>max</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>rating</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>5</td>\n",
       "      <td>428.498047</td>\n",
       "      <td>3680</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>9</td>\n",
       "      <td>452.604594</td>\n",
       "      <td>10745</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>8</td>\n",
       "      <td>460.968445</td>\n",
       "      <td>5112</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>7</td>\n",
       "      <td>463.788153</td>\n",
       "      <td>3030</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>6</td>\n",
       "      <td>477.689911</td>\n",
       "      <td>2042</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>4</td>\n",
       "      <td>467.608316</td>\n",
       "      <td>2202</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>6</td>\n",
       "      <td>485.257052</td>\n",
       "      <td>3055</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>3</td>\n",
       "      <td>483.256878</td>\n",
       "      <td>4086</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>3</td>\n",
       "      <td>477.376968</td>\n",
       "      <td>6166</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>3</td>\n",
       "      <td>442.931619</td>\n",
       "      <td>6170</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       len                   \n",
       "       min        mean    max\n",
       "rating                       \n",
       "1        5  428.498047   3680\n",
       "2        9  452.604594  10745\n",
       "3        8  460.968445   5112\n",
       "4        7  463.788153   3030\n",
       "5        6  477.689911   2042\n",
       "6        4  467.608316   2202\n",
       "7        6  485.257052   3055\n",
       "8        3  483.256878   4086\n",
       "9        3  477.376968   6166\n",
       "10       3  442.931619   6170"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "training_data[['rating','len']].groupby(['rating']).agg(['min','mean','max'])"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f79092c4",
   "metadata": {},
   "source": [
    "# Cleaning of the reviews"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "8d69746c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\"My son is halfway through his fourth week of Intuniv. We became concerned when he began this last week, when he started taking the highest dose he will be on. For two days, he could hardly get out of bed, was very cranky, and slept for nearly 8 hours on a drive home from school vacation (very unusual for him.) I called his doctor on Monday morning and she said to stick it out a few days. See how he did at school, and with getting up in the morning. The last two days have been problem free. He is MUCH more agreeable than ever. He is less emotional (a good thing), less cranky. He is remembering all the things he should. Overall his behavior is better. \n",
      "We have tried many different medications and so far this is the most effective.\"\n"
     ]
    }
   ],
   "source": [
    "# Parcing through a sample of reviews\n",
    "\n",
    "sample_review = training_data['review'][1]\n",
    "print(sample_review)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "29dcf9dc",
   "metadata": {},
   "source": [
    "The reviews have punctuations, stop words and capitalized"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "894e42ca",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>uniqueID</th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "      <th>len</th>\n",
       "      <th>cleaned_review</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>206461</td>\n",
       "      <td>Valsartan</td>\n",
       "      <td>Left Ventricular Dysfunction</td>\n",
       "      <td>\"It has no side effect, I take it in combinati...</td>\n",
       "      <td>9</td>\n",
       "      <td>May 20, 2012</td>\n",
       "      <td>27</td>\n",
       "      <td>79</td>\n",
       "      <td>\"it has no side effect, i take it in combinati...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>95260</td>\n",
       "      <td>Guanfacine</td>\n",
       "      <td>ADHD</td>\n",
       "      <td>\"My son is halfway through his fourth week of ...</td>\n",
       "      <td>8</td>\n",
       "      <td>April 27, 2010</td>\n",
       "      <td>192</td>\n",
       "      <td>740</td>\n",
       "      <td>\"my son is halfway through his fourth week of ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>92703</td>\n",
       "      <td>Lybrel</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>\"I used to take another oral contraceptive, wh...</td>\n",
       "      <td>5</td>\n",
       "      <td>December 14, 2009</td>\n",
       "      <td>17</td>\n",
       "      <td>754</td>\n",
       "      <td>\"i used to take another oral contraceptive, wh...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>138000</td>\n",
       "      <td>Ortho Evra</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>\"This is my first time using any form of birth...</td>\n",
       "      <td>8</td>\n",
       "      <td>November 3, 2015</td>\n",
       "      <td>10</td>\n",
       "      <td>448</td>\n",
       "      <td>\"this is my first time using any form of birth...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>35696</td>\n",
       "      <td>Buprenorphine / naloxone</td>\n",
       "      <td>Opiate Dependence</td>\n",
       "      <td>\"Suboxone has completely turned my life around...</td>\n",
       "      <td>9</td>\n",
       "      <td>November 27, 2016</td>\n",
       "      <td>37</td>\n",
       "      <td>719</td>\n",
       "      <td>\"suboxone has completely turned my life around...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   uniqueID                  drugName                     condition  \\\n",
       "0    206461                 Valsartan  Left Ventricular Dysfunction   \n",
       "1     95260                Guanfacine                          ADHD   \n",
       "2     92703                    Lybrel                 Birth Control   \n",
       "3    138000                Ortho Evra                 Birth Control   \n",
       "4     35696  Buprenorphine / naloxone             Opiate Dependence   \n",
       "\n",
       "                                              review  rating  \\\n",
       "0  \"It has no side effect, I take it in combinati...       9   \n",
       "1  \"My son is halfway through his fourth week of ...       8   \n",
       "2  \"I used to take another oral contraceptive, wh...       5   \n",
       "3  \"This is my first time using any form of birth...       8   \n",
       "4  \"Suboxone has completely turned my life around...       9   \n",
       "\n",
       "                date  usefulCount  len  \\\n",
       "0       May 20, 2012           27   79   \n",
       "1     April 27, 2010          192  740   \n",
       "2  December 14, 2009           17  754   \n",
       "3   November 3, 2015           10  448   \n",
       "4  November 27, 2016           37  719   \n",
       "\n",
       "                                      cleaned_review  \n",
       "0  \"it has no side effect, i take it in combinati...  \n",
       "1  \"my son is halfway through his fourth week of ...  \n",
       "2  \"i used to take another oral contraceptive, wh...  \n",
       "3  \"this is my first time using any form of birth...  \n",
       "4  \"suboxone has completely turned my life around...  "
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# removing the capitalization\n",
    "\n",
    "training_data['cleaned_review'] = training_data['review'].str.lower()\n",
    "training_data.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "b4e31e3b",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package stopwords to\n",
      "[nltk_data]     C:\\Users\\prana\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package stopwords is already up-to-date!\n",
      "[nltk_data] Downloading package punkt to\n",
      "[nltk_data]     C:\\Users\\prana\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package punkt is already up-to-date!\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "nltk.download('stopwords')\n",
    "nltk.download('punkt')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "03d6ee75",
   "metadata": {},
   "outputs": [],
   "source": [
    "#removing punctuations\n",
    "\n",
    "def punctuation_removal(messy_str):\n",
    "    clean_list = [char for char in messy_str if char not in string.punctuation]\n",
    "    clean_str = ''.join(clean_list)\n",
    "    return clean_str\n",
    "\n",
    "training_data['review'] = training_data['review'].apply(punctuation_removal)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "77b239bb",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['i', 'me', 'my', 'myself', 'we', 'our', 'ours', 'ourselves', 'you', \"you're\", \"you've\", \"you'll\", \"you'd\", 'your', 'yours', 'yourself', 'yourselves', 'he', 'him', 'his', 'himself', 'she', \"she's\", 'her', 'hers', 'herself', 'it', \"it's\", 'its', 'itself', 'they', 'them', 'their', 'theirs', 'themselves', 'what', 'which', 'who', 'whom', 'this', 'that', \"that'll\", 'these', 'those', 'am', 'is', 'are', 'was', 'were', 'be', 'been', 'being', 'have', 'has', 'had', 'having', 'do', 'does', 'did', 'doing', 'a', 'an', 'the', 'and', 'but', 'if', 'or', 'because', 'as', 'until', 'while', 'of', 'at', 'by', 'for', 'with', 'about', 'against', 'between', 'into', 'through', 'during', 'before', 'after', 'above', 'below', 'to', 'from', 'up', 'down', 'in', 'out', 'on', 'off', 'over', 'under', 'again', 'further', 'then', 'once', 'here', 'there', 'when', 'where', 'why', 'how', 'all', 'any', 'both', 'each', 'few', 'more', 'most', 'other', 'some', 'such', 'no', 'nor', 'not', 'only', 'own', 'same', 'so', 'than', 'too', 'very', 's', 't', 'can', 'will', 'just', 'don', \"don't\", 'should', \"should've\", 'now', 'd', 'll', 'm', 'o', 're', 've', 'y', 'ain', 'aren', \"aren't\", 'couldn', \"couldn't\", 'didn', \"didn't\", 'doesn', \"doesn't\", 'hadn', \"hadn't\", 'hasn', \"hasn't\", 'haven', \"haven't\", 'isn', \"isn't\", 'ma', 'mightn', \"mightn't\", 'mustn', \"mustn't\", 'needn', \"needn't\", 'shan', \"shan't\", 'shouldn', \"shouldn't\", 'wasn', \"wasn't\", 'weren', \"weren't\", 'won', \"won't\", 'wouldn', \"wouldn't\"]\n"
     ]
    }
   ],
   "source": [
    "# Removing the stop words and punctuations\n",
    "from nltk.corpus import stopwords\n",
    "from nltk.tokenize import word_tokenize\n",
    "import string\n",
    "\n",
    "stop_word_list = (stopwords.words('english'))\n",
    "print(stop_word_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "44cc7656",
   "metadata": {},
   "outputs": [],
   "source": [
    "stop_words = []\n",
    "\n",
    "for item in stop_word_list: \n",
    "    new_item = punctuation_removal(item)\n",
    "    stop_words.append(new_item) \n",
    "\n",
    "def stopwords_removal(messy_str):\n",
    "    messy_str = word_tokenize(messy_str)\n",
    "    return [word.lower() for word in messy_str \n",
    "            if word.lower() not in stop_words ]\n",
    "\n",
    "training_data['review'] = training_data['review'].apply(stopwords_removal)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "d9b9e2ca",
   "metadata": {},
   "outputs": [],
   "source": [
    "#removing number\n",
    "import re\n",
    "def drop_numbers(list_text):\n",
    "    list_text_new = []\n",
    "    for i in list_text:\n",
    "        if not re.search('\\d', i):\n",
    "            list_text_new.append(i)\n",
    "    return ' '.join(list_text_new)\n",
    "\n",
    "training_data['review'] = training_data['review'].apply(drop_numbers)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "52303b54",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>uniqueID</th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "      <th>len</th>\n",
       "      <th>cleaned_review</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>206461</td>\n",
       "      <td>Valsartan</td>\n",
       "      <td>Left Ventricular Dysfunction</td>\n",
       "      <td>side effect take combination bystolic mg fish oil</td>\n",
       "      <td>9</td>\n",
       "      <td>May 20, 2012</td>\n",
       "      <td>27</td>\n",
       "      <td>79</td>\n",
       "      <td>\"it has no side effect, i take it in combinati...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>95260</td>\n",
       "      <td>Guanfacine</td>\n",
       "      <td>ADHD</td>\n",
       "      <td>son halfway fourth week intuniv became concern...</td>\n",
       "      <td>8</td>\n",
       "      <td>April 27, 2010</td>\n",
       "      <td>192</td>\n",
       "      <td>740</td>\n",
       "      <td>\"my son is halfway through his fourth week of ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   uniqueID    drugName                     condition  \\\n",
       "0    206461   Valsartan  Left Ventricular Dysfunction   \n",
       "1     95260  Guanfacine                          ADHD   \n",
       "\n",
       "                                              review  rating            date  \\\n",
       "0  side effect take combination bystolic mg fish oil       9    May 20, 2012   \n",
       "1  son halfway fourth week intuniv became concern...       8  April 27, 2010   \n",
       "\n",
       "   usefulCount  len                                     cleaned_review  \n",
       "0           27   79  \"it has no side effect, i take it in combinati...  \n",
       "1          192  740  \"my son is halfway through his fourth week of ...  "
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "training_data.head(2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "b6457ee4",
   "metadata": {},
   "outputs": [],
   "source": [
    "#Lemmatization\n",
    "from nltk.stem import WordNetLemmatizer\n",
    "\n",
    "# Create WordNetLemmatizer object\n",
    "wnl = WordNetLemmatizer()\n",
    "\n",
    "def lemma(list_text):\n",
    "    list_new = []\n",
    "    for i in list_text.split(' '):\n",
    "        wnl.lemmatize(i)\n",
    "        list_new.append(i)\n",
    "    return ' '.join(list_new)\n",
    "    \n",
    "training_data['cleaned_review'] = training_data['review'].apply(lemma)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "a81cd5a3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>uniqueID</th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "      <th>len</th>\n",
       "      <th>cleaned_review</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>206461</td>\n",
       "      <td>Valsartan</td>\n",
       "      <td>Left Ventricular Dysfunction</td>\n",
       "      <td>side effect take combination bystolic mg fish oil</td>\n",
       "      <td>9</td>\n",
       "      <td>May 20, 2012</td>\n",
       "      <td>27</td>\n",
       "      <td>79</td>\n",
       "      <td>side effect take combination bystolic mg fish oil</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>95260</td>\n",
       "      <td>Guanfacine</td>\n",
       "      <td>ADHD</td>\n",
       "      <td>son halfway fourth week intuniv became concern...</td>\n",
       "      <td>8</td>\n",
       "      <td>April 27, 2010</td>\n",
       "      <td>192</td>\n",
       "      <td>740</td>\n",
       "      <td>son halfway fourth week intuniv became concern...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>92703</td>\n",
       "      <td>Lybrel</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>used take another oral contraceptive pill cycl...</td>\n",
       "      <td>5</td>\n",
       "      <td>December 14, 2009</td>\n",
       "      <td>17</td>\n",
       "      <td>754</td>\n",
       "      <td>used take another oral contraceptive pill cycl...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>138000</td>\n",
       "      <td>Ortho Evra</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>first time using form birth control glad went ...</td>\n",
       "      <td>8</td>\n",
       "      <td>November 3, 2015</td>\n",
       "      <td>10</td>\n",
       "      <td>448</td>\n",
       "      <td>first time using form birth control glad went ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>35696</td>\n",
       "      <td>Buprenorphine / naloxone</td>\n",
       "      <td>Opiate Dependence</td>\n",
       "      <td>suboxone completely turned life around feel he...</td>\n",
       "      <td>9</td>\n",
       "      <td>November 27, 2016</td>\n",
       "      <td>37</td>\n",
       "      <td>719</td>\n",
       "      <td>suboxone completely turned life around feel he...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   uniqueID                  drugName                     condition  \\\n",
       "0    206461                 Valsartan  Left Ventricular Dysfunction   \n",
       "1     95260                Guanfacine                          ADHD   \n",
       "2     92703                    Lybrel                 Birth Control   \n",
       "3    138000                Ortho Evra                 Birth Control   \n",
       "4     35696  Buprenorphine / naloxone             Opiate Dependence   \n",
       "\n",
       "                                              review  rating  \\\n",
       "0  side effect take combination bystolic mg fish oil       9   \n",
       "1  son halfway fourth week intuniv became concern...       8   \n",
       "2  used take another oral contraceptive pill cycl...       5   \n",
       "3  first time using form birth control glad went ...       8   \n",
       "4  suboxone completely turned life around feel he...       9   \n",
       "\n",
       "                date  usefulCount  len  \\\n",
       "0       May 20, 2012           27   79   \n",
       "1     April 27, 2010          192  740   \n",
       "2  December 14, 2009           17  754   \n",
       "3   November 3, 2015           10  448   \n",
       "4  November 27, 2016           37  719   \n",
       "\n",
       "                                      cleaned_review  \n",
       "0  side effect take combination bystolic mg fish oil  \n",
       "1  son halfway fourth week intuniv became concern...  \n",
       "2  used take another oral contraceptive pill cycl...  \n",
       "3  first time using form birth control glad went ...  \n",
       "4  suboxone completely turned life around feel he...  "
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "training_data.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "178e8ce9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>uniqueID</th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "      <th>cleaned_review</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>163740</td>\n",
       "      <td>Mirtazapine</td>\n",
       "      <td>Depression</td>\n",
       "      <td>tried antidepressants years citalopram fluoxet...</td>\n",
       "      <td>10</td>\n",
       "      <td>February 28, 2012</td>\n",
       "      <td>22</td>\n",
       "      <td>tried antidepressants years citalopram fluoxet...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>206473</td>\n",
       "      <td>Mesalamine</td>\n",
       "      <td>Crohn's Disease, Maintenance</td>\n",
       "      <td>son disease done well asacol complaints shows ...</td>\n",
       "      <td>8</td>\n",
       "      <td>May 17, 2009</td>\n",
       "      <td>17</td>\n",
       "      <td>son disease done well asacol complaints shows ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>159672</td>\n",
       "      <td>Bactrim</td>\n",
       "      <td>Urinary Tract Infection</td>\n",
       "      <td>quick reduction symptoms</td>\n",
       "      <td>9</td>\n",
       "      <td>September 29, 2017</td>\n",
       "      <td>3</td>\n",
       "      <td>quick reduction symptoms</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>39293</td>\n",
       "      <td>Contrave</td>\n",
       "      <td>Weight Loss</td>\n",
       "      <td>contrave combines drugs used alcohol smoking o...</td>\n",
       "      <td>9</td>\n",
       "      <td>March 5, 2017</td>\n",
       "      <td>35</td>\n",
       "      <td>contrave combines drugs used alcohol smoking o...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>97768</td>\n",
       "      <td>Cyclafem 1 / 35</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>birth control one cycle reading reviews type s...</td>\n",
       "      <td>9</td>\n",
       "      <td>October 22, 2015</td>\n",
       "      <td>4</td>\n",
       "      <td>birth control one cycle reading reviews type s...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   uniqueID         drugName                     condition  \\\n",
       "0    163740      Mirtazapine                    Depression   \n",
       "1    206473       Mesalamine  Crohn's Disease, Maintenance   \n",
       "2    159672          Bactrim       Urinary Tract Infection   \n",
       "3     39293         Contrave                   Weight Loss   \n",
       "4     97768  Cyclafem 1 / 35                 Birth Control   \n",
       "\n",
       "                                              review  rating  \\\n",
       "0  tried antidepressants years citalopram fluoxet...      10   \n",
       "1  son disease done well asacol complaints shows ...       8   \n",
       "2                           quick reduction symptoms       9   \n",
       "3  contrave combines drugs used alcohol smoking o...       9   \n",
       "4  birth control one cycle reading reviews type s...       9   \n",
       "\n",
       "                 date  usefulCount  \\\n",
       "0   February 28, 2012           22   \n",
       "1        May 17, 2009           17   \n",
       "2  September 29, 2017            3   \n",
       "3       March 5, 2017           35   \n",
       "4    October 22, 2015            4   \n",
       "\n",
       "                                      cleaned_review  \n",
       "0  tried antidepressants years citalopram fluoxet...  \n",
       "1  son disease done well asacol complaints shows ...  \n",
       "2                           quick reduction symptoms  \n",
       "3  contrave combines drugs used alcohol smoking o...  \n",
       "4  birth control one cycle reading reviews type s...  "
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Test data reviews\n",
    "\n",
    "test_data['cleaned_review'] = test_data['review'].str.lower()\n",
    "\n",
    "test_data['review'] = test_data['review'].apply(punctuation_removal)\n",
    "\n",
    "test_data['review'] = test_data['review'].apply(stopwords_removal)\n",
    "\n",
    "test_data['review'] = test_data['review'].apply(drop_numbers)\n",
    "\n",
    "test_data['cleaned_review'] = test_data['review'].apply(lemma)\n",
    "\n",
    "test_data.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "4d8c86b6",
   "metadata": {},
   "outputs": [],
   "source": [
    "training_data = training_data.drop(columns ='review')\n",
    "test_data = test_data.drop(columns='review')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "207dbd03",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>uniqueID</th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "      <th>cleaned_review</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>163740</td>\n",
       "      <td>Mirtazapine</td>\n",
       "      <td>Depression</td>\n",
       "      <td>10</td>\n",
       "      <td>February 28, 2012</td>\n",
       "      <td>22</td>\n",
       "      <td>tried antidepressants years citalopram fluoxet...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>206473</td>\n",
       "      <td>Mesalamine</td>\n",
       "      <td>Crohn's Disease, Maintenance</td>\n",
       "      <td>8</td>\n",
       "      <td>May 17, 2009</td>\n",
       "      <td>17</td>\n",
       "      <td>son disease done well asacol complaints shows ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>159672</td>\n",
       "      <td>Bactrim</td>\n",
       "      <td>Urinary Tract Infection</td>\n",
       "      <td>9</td>\n",
       "      <td>September 29, 2017</td>\n",
       "      <td>3</td>\n",
       "      <td>quick reduction symptoms</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>39293</td>\n",
       "      <td>Contrave</td>\n",
       "      <td>Weight Loss</td>\n",
       "      <td>9</td>\n",
       "      <td>March 5, 2017</td>\n",
       "      <td>35</td>\n",
       "      <td>contrave combines drugs used alcohol smoking o...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>97768</td>\n",
       "      <td>Cyclafem 1 / 35</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>9</td>\n",
       "      <td>October 22, 2015</td>\n",
       "      <td>4</td>\n",
       "      <td>birth control one cycle reading reviews type s...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   uniqueID         drugName                     condition  rating  \\\n",
       "0    163740      Mirtazapine                    Depression      10   \n",
       "1    206473       Mesalamine  Crohn's Disease, Maintenance       8   \n",
       "2    159672          Bactrim       Urinary Tract Infection       9   \n",
       "3     39293         Contrave                   Weight Loss       9   \n",
       "4     97768  Cyclafem 1 / 35                 Birth Control       9   \n",
       "\n",
       "                 date  usefulCount  \\\n",
       "0   February 28, 2012           22   \n",
       "1        May 17, 2009           17   \n",
       "2  September 29, 2017            3   \n",
       "3       March 5, 2017           35   \n",
       "4    October 22, 2015            4   \n",
       "\n",
       "                                      cleaned_review  \n",
       "0  tried antidepressants years citalopram fluoxet...  \n",
       "1  son disease done well asacol complaints shows ...  \n",
       "2                           quick reduction symptoms  \n",
       "3  contrave combines drugs used alcohol smoking o...  \n",
       "4  birth control one cycle reading reviews type s...  "
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test_data.head(5)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c0a45c45",
   "metadata": {},
   "source": [
    "# Modelling"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "d25af5b8",
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "from sklearn.metrics import confusion_matrix\n",
    "from sklearn.naive_bayes import MultinomialNB\n",
    "from sklearn.ensemble import RandomForestClassifier"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "25ae3748",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Creating TF-IDF vectorizer and transforming the corpus\n",
    "\n",
    "vectorizer = TfidfVectorizer()\n",
    "X_train = (vectorizer.fit_transform(training_data.cleaned_review))\n",
    "\n",
    "# transforms test reviews to above vectorized format\n",
    "X_test = (vectorizer.transform(test_data.cleaned_review))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "3355e949",
   "metadata": {},
   "outputs": [],
   "source": [
    "#y_train and y_test\n",
    "y_train= training_data['condition']\n",
    "\n",
    "y_test = test_data['condition']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "79d11f9f",
   "metadata": {},
   "outputs": [],
   "source": [
    "#binary encoding the y_train and y_test\n",
    "clf = MultinomialNB().fit(X_train, y_train)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "693eb2b9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Accuracy: 0.3057358194161321\n",
      "Confusion Matrix\n",
      "[[0 0 0 ... 0 0 0]\n",
      " [0 0 0 ... 0 0 0]\n",
      " [0 0 0 ... 0 0 0]\n",
      " ...\n",
      " [0 0 0 ... 0 0 0]\n",
      " [0 0 0 ... 0 0 0]\n",
      " [0 0 0 ... 0 0 0]]\n"
     ]
    }
   ],
   "source": [
    "pred = clf.predict(X_test)\n",
    "\n",
    "print(\"Accuracy: %s\" % str(clf.score(X_test, y_test)))\n",
    "print(\"Confusion Matrix\")\n",
    "print(confusion_matrix(pred, y_test))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "5bec50cb",
   "metadata": {},
   "outputs": [],
   "source": [
    "# import time\n",
    "\n",
    "# start = time.time()\n",
    "# rfc_rating = RandomForestClassifier(n_estimators=100, random_state=42, max_depth = 10000, min_samples_split = 0.001)\n",
    "\n",
    "# rfc_rating.fit(X_train, y_train)\n",
    "\n",
    "# end = time.time()\n",
    "# print(\"Training time: %s\" % str(end-start))\n",
    "\n",
    "# # Evaluates model on test set\n",
    "# pred = rfc_rating.predict(X_test)\n",
    "\n",
    "# print(\"Accuracy: %s\" % str(rfc_rating.score(X_test, y_test)))\n",
    "# print(\"Confusion Matrix\")\n",
    "# print(confusion_matrix(pred, y_test))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "23fbfd22",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.7016513624207514\n",
      "                                                                precision    recall  f1-score   support\n",
      "\n",
      "                    0</span> users found this comment helpful.       0.00      0.00      0.00        24\n",
      "                  100</span> users found this comment helpful.       0.00      0.00      0.00         1\n",
      "                  105</span> users found this comment helpful.       0.00      0.00      0.00         1\n",
      "                   10</span> users found this comment helpful.       0.00      0.00      0.00        10\n",
      "                   11</span> users found this comment helpful.       0.00      0.00      0.00         4\n",
      "                   12</span> users found this comment helpful.       0.00      0.00      0.00         9\n",
      "                  135</span> users found this comment helpful.       0.00      0.00      0.00         1\n",
      "                   13</span> users found this comment helpful.       0.00      0.00      0.00         5\n",
      "                   14</span> users found this comment helpful.       0.00      0.00      0.00         4\n",
      "                   15</span> users found this comment helpful.       0.00      0.00      0.00         5\n",
      "                   16</span> users found this comment helpful.       0.00      0.00      0.00         2\n",
      "                   17</span> users found this comment helpful.       0.00      0.00      0.00         5\n",
      "                   18</span> users found this comment helpful.       0.00      0.00      0.00         5\n",
      "                    1</span> users found this comment helpful.       0.00      0.00      0.00        31\n",
      "                   20</span> users found this comment helpful.       0.00      0.00      0.00         2\n",
      "                   21</span> users found this comment helpful.       0.00      0.00      0.00         3\n",
      "                   22</span> users found this comment helpful.       0.00      0.00      0.00         2\n",
      "                   23</span> users found this comment helpful.       0.00      0.00      0.00         3\n",
      "                   24</span> users found this comment helpful.       0.00      0.00      0.00         1\n",
      "                   25</span> users found this comment helpful.       0.00      0.00      0.00         2\n",
      "                   27</span> users found this comment helpful.       0.00      0.00      0.00         2\n",
      "                   28</span> users found this comment helpful.       0.00      0.00      0.00         2\n",
      "                   29</span> users found this comment helpful.       0.00      0.00      0.00         1\n",
      "                    2</span> users found this comment helpful.       0.00      0.00      0.00        20\n",
      "                   31</span> users found this comment helpful.       0.00      0.00      0.00         1\n",
      "                   32</span> users found this comment helpful.       0.00      0.00      0.00         2\n",
      "                   33</span> users found this comment helpful.       0.00      0.00      0.00         2\n",
      "                   34</span> users found this comment helpful.       0.00      0.00      0.00         2\n",
      "                   35</span> users found this comment helpful.       0.00      0.00      0.00         1\n",
      "                   37</span> users found this comment helpful.       0.00      0.00      0.00         1\n",
      "                   38</span> users found this comment helpful.       0.00      0.00      0.00         1\n",
      "                   39</span> users found this comment helpful.       0.00      0.00      0.00         5\n",
      "                    3</span> users found this comment helpful.       0.00      0.00      0.00        17\n",
      "                   41</span> users found this comment helpful.       0.00      0.00      0.00         1\n",
      "                    4</span> users found this comment helpful.       0.00      0.00      0.00        21\n",
      "                   51</span> users found this comment helpful.       0.00      0.00      0.00         2\n",
      "                   55</span> users found this comment helpful.       0.00      0.00      0.00         2\n",
      "                    5</span> users found this comment helpful.       0.00      0.00      0.00        19\n",
      "                    6</span> users found this comment helpful.       0.00      0.00      0.00        18\n",
      "                   70</span> users found this comment helpful.       0.00      0.00      0.00         1\n",
      "                    7</span> users found this comment helpful.       0.00      0.00      0.00        13\n",
      "                   83</span> users found this comment helpful.       0.00      0.00      0.00         1\n",
      "                    8</span> users found this comment helpful.       0.00      0.00      0.00         7\n",
      "                    9</span> users found this comment helpful.       0.00      0.00      0.00         9\n",
      "                                                          ADHD       0.75      0.88      0.81      1126\n",
      "                                          AIDS Related Wasting       1.00      0.50      0.67         2\n",
      "                                     Abnormal Uterine Bleeding       0.62      0.28      0.38       648\n",
      "                                                      Abortion       0.00      0.00      0.00         2\n",
      "                                        Acetaminophen Overdose       0.00      0.00      0.00         1\n",
      "                                                          Acne       0.79      0.90      0.84      1847\n",
      "                                             Actinic Keratosis       0.00      0.00      0.00         8\n",
      "                                       Acute Coronary Syndrome       1.00      0.45      0.62        11\n",
      "                                  Acute Lymphoblastic Leukemia       0.00      0.00      0.00         2\n",
      "                                 Acute Nonlymphocytic Leukemia       0.00      0.00      0.00         1\n",
      "                                          Acute Otitis Externa       0.00      0.00      0.00         2\n",
      "                                  Acute Promyelocytic Leukemia       0.00      0.00      0.00         1\n",
      "                                             Addison's Disease       1.00      0.50      0.67         2\n",
      "                                  Adrenocortical Insufficiency       0.00      0.00      0.00         3\n",
      "                         Adult Human Growth Hormone Deficiency       0.00      0.00      0.00         1\n",
      "                                                Agitated State       0.00      0.00      0.00         8\n",
      "                                                     Agitation       0.00      0.00      0.00         6\n",
      "                                            Alcohol Dependence       0.81      0.88      0.84       130\n",
      "                                            Alcohol Withdrawal       0.81      0.51      0.63        68\n",
      "                                            Allergic Reactions       1.00      0.13      0.24        30\n",
      "                                             Allergic Rhinitis       0.57      0.71      0.63       350\n",
      "                                            Allergic Urticaria       0.00      0.00      0.00         6\n",
      "                                                     Allergies       0.70      0.14      0.24        49\n",
      "                                                      Alopecia       0.71      0.67      0.69        36\n",
      "                       Alpha-1 Proteinase Inhibitor Deficiency       0.00      0.00      0.00         2\n",
      "                                           Alzheimer's Disease       0.79      0.69      0.73        32\n",
      "                                                     Amebiasis       0.00      0.00      0.00         3\n",
      "                                                    Amenorrhea       0.92      0.46      0.62        26\n",
      "                                      Anal Fissure and Fistula       1.00      0.40      0.57         5\n",
      "                                                  Anal Itching       0.00      0.00      0.00         4\n",
      "                                        Anaplastic Astrocytoma       1.00      1.00      1.00         1\n",
      "                                         Androgenetic Alopecia       1.00      0.18      0.30        17\n",
      "                                                        Anemia       1.00      0.10      0.18        10\n",
      "                  Anemia Associated with Chronic Renal Failure       1.00      0.38      0.55         8\n",
      "                                  Anemia, Chemotherapy Induced       0.00      0.00      0.00         1\n",
      "                                           Anemia, Sickle Cell       1.00      0.25      0.40         4\n",
      "                                                    Anesthesia       0.93      0.73      0.82        86\n",
      "                                                        Angina       0.81      0.70      0.75        30\n",
      "                                   Angina Pectoris Prophylaxis       1.00      0.11      0.20         9\n",
      "                                        Ankylosing Spondylitis       0.94      0.48      0.63        61\n",
      "                                                      Anorexia       1.00      0.10      0.18        31\n",
      "                                                       Anthrax       0.00      0.00      0.00         1\n",
      "                                     Antiphospholipid Syndrome       0.00      0.00      0.00         2\n",
      "                                                       Anxiety       0.51      0.68      0.59      1908\n",
      "                                            Anxiety and Stress       0.61      0.18      0.28       573\n",
      "                                                 Aphthous Ulce       0.00      0.00      0.00         3\n",
      "                                               Aplastic Anemia       0.00      0.00      0.00         3\n",
      "                                                    Arrhythmia       1.00      0.43      0.60        42\n",
      "                                             Asperger Syndrome       0.00      0.00      0.00         7\n",
      "                                   Aspergillosis, Aspergilloma       0.00      0.00      0.00         1\n",
      "                                                        Asthma       0.84      0.21      0.33        77\n",
      "                                           Asthma, Maintenance       0.50      0.67      0.57       158\n",
      "                                                 Asthma, acute       0.73      0.32      0.45        34\n",
      "                                             Atopic Dermatitis       0.69      0.46      0.56        54\n",
      "                                           Atrial Fibrillation       0.64      0.72      0.68        75\n",
      "                                                 Atrial Flutte       0.00      0.00      0.00         8\n",
      "                                           Atrophic Urethritis       0.00      0.00      0.00         4\n",
      "                                            Atrophic Vaginitis       0.86      0.72      0.78        53\n",
      "                                   Auditory Processing Disorde       0.00      0.00      0.00         4\n",
      "                                                        Autism       0.64      0.23      0.33        31\n",
      "                                   Autoimmune Hemolytic Anemia       0.00      0.00      0.00         1\n",
      "                                          Autoimmune Hepatitis       1.00      0.33      0.50         6\n",
      "                                    B12 Nutritional Deficiency       0.00      0.00      0.00         1\n",
      "                                                     Back Pain       0.45      0.08      0.13       192\n",
      "                                                    Bacteremia       0.00      0.00      0.00         2\n",
      "                             Bacterial Endocarditis Prevention       0.00      0.00      0.00         3\n",
      "                                           Bacterial Infection       0.45      0.38      0.42       307\n",
      "                                      Bacterial Skin Infection       0.77      0.44      0.56        45\n",
      "                                           Bacterial Vaginitis       0.62      0.66      0.64       153\n",
      "                                           Barrett's Esophagus       0.00      0.00      0.00        18\n",
      "                                          Basal Cell Carcinoma       1.00      0.47      0.64        19\n",
      "                                              Behcet's Disease       0.00      0.00      0.00         2\n",
      "                                         Benign Essential Trem       0.82      0.64      0.72        28\n",
      "                                  Benign Prostatic Hyperplasia       0.80      0.76      0.78       165\n",
      "                                     Benzodiazepine Withdrawal       0.00      0.00      0.00         7\n",
      "                                             Biliary Cirrhosis       1.00      0.20      0.33         5\n",
      "                                          Binge Eating Disorde       1.00      0.38      0.55        29\n",
      "                                               Bipolar Disorde       0.66      0.73      0.69      1380\n",
      "                                                 Birth Control       0.83      0.97      0.89      9648\n",
      "                                             Bladder Infection       0.69      0.19      0.30       130\n",
      "                                              Bleeding Disorde       0.00      0.00      0.00         2\n",
      "                                                   Blepharitis       0.00      0.00      0.00         1\n",
      "                                       Body Dysmorphic Disorde       0.00      0.00      0.00         1\n",
      "                                                Bone infection       1.00      0.25      0.40         4\n",
      "                                Borderline Personality Disorde       0.33      0.02      0.04        50\n",
      "                                             Bowel Preparation       0.83      0.96      0.89       639\n",
      "                                             Breakthrough Pain       1.00      0.21      0.35        14\n",
      "                                                  Breast Cance       0.76      0.79      0.77        99\n",
      "                                       Breast Cancer, Adjuvant       0.00      0.00      0.00         6\n",
      "                                     Breast Cancer, Metastatic       0.78      0.54      0.64        26\n",
      "                                     Breast Cancer, Palliative       0.00      0.00      0.00         2\n",
      "                                     Breast Cancer, Prevention       0.00      0.00      0.00         5\n",
      "                                                    Bronchitis       0.65      0.48      0.55       157\n",
      "                                      Bronchospasm Prophylaxis       1.00      0.14      0.25         7\n",
      "                                                       Bulimia       0.80      0.50      0.62        16\n",
      "                                            Bullous Pemphigoid       1.00      0.25      0.40         4\n",
      "                                        Burning Mouth Syndrome       1.00      0.20      0.33         5\n",
      "                                               Burns, External       1.00      0.23      0.38        13\n",
      "                                                      Bursitis       1.00      0.33      0.50         3\n",
      "                                               CMV Prophylaxis       0.00      0.00      0.00         1\n",
      "                                                          COPD       0.63      0.38      0.47        45\n",
      "                                                   COPD, Acute       1.00      0.20      0.33         5\n",
      "                                             COPD, Maintenance       0.77      0.53      0.63        78\n",
      "                                                      Cachexia       0.00      0.00      0.00         1\n",
      "                                                         Cance       0.00      0.00      0.00         2\n",
      "                                                     Cataplexy       0.00      0.00      0.00         2\n",
      "                                                Cerebral Edema       0.00      0.00      0.00         1\n",
      "                                           Cerebral Spasticity       0.00      0.00      0.00         2\n",
      "                                             Cervical Dystonia       0.73      0.38      0.50        21\n",
      "                                           Chlamydia Infection       0.84      0.52      0.64        98\n",
      "                                      Chronic Fatigue Syndrome       0.83      0.18      0.29        28\n",
      "                               Chronic Idiopathic Constipation       0.71      0.23      0.34        22\n",
      "     Chronic Inflammatory Demyelinating Polyradiculoneuropathy       0.00      0.00      0.00         1\n",
      "                                  Chronic Lymphocytic Leukemia       1.00      0.45      0.62        11\n",
      "                                  Chronic Myelogenous Leukemia       0.78      0.81      0.79        26\n",
      "                                       Chronic Myofascial Pain       0.00      0.00      0.00         2\n",
      "                                                  Chronic Pain       0.66      0.14      0.23       485\n",
      "                                          Chronic Pancreatitis       1.00      0.40      0.57         5\n",
      "                                            Chronic Spasticity       1.00      0.50      0.67         2\n",
      "                                         Clostridial Infection       0.25      0.12      0.17         8\n",
      "                                             Cluster Headaches       0.62      0.46      0.52        46\n",
      "                                            Coccidioidomycosis       1.00      1.00      1.00         1\n",
      "                                                    Cold Sores       0.70      0.86      0.77       105\n",
      "                                                 Cold Symptoms       0.80      0.11      0.20        35\n",
      "                                              Colorectal Cance       1.00      1.00      1.00         2\n",
      "                                           Computed Tomography       1.00      0.25      0.40         4\n",
      "                                         Condylomata Acuminata       0.00      0.00      0.00         5\n",
      "                                                Conjunctivitis       1.00      0.29      0.44         7\n",
      "                                      Conjunctivitis, Allergic       0.75      0.43      0.55        21\n",
      "                                     Conjunctivitis, Bacterial       0.86      0.33      0.48        18\n",
      "                                                  Constipation       0.65      0.86      0.74       525\n",
      "                                           Constipation, Acute       0.00      0.00      0.00        19\n",
      "                                         Constipation, Chronic       0.65      0.64      0.64       179\n",
      "                                    Constipation, Drug Induced       0.81      0.49      0.61        77\n",
      "                                    Corneal Refractive Surgery       0.00      0.00      0.00         2\n",
      "                                       Coronary Artery Disease       0.00      0.00      0.00         1\n",
      "                                               Costochondritis       0.00      0.00      0.00         2\n",
      "                                                         Cough       0.68      0.77      0.72       297\n",
      "                                    Cough and Nasal Congestion       0.67      0.53      0.59       113\n",
      "                                               Crohn's Disease       0.71      0.23      0.34        53\n",
      "                                        Crohn's Disease, Acute       1.00      0.18      0.31        11\n",
      "                                  Crohn's Disease, Maintenance       0.68      0.64      0.66        74\n",
      "                                         Cutaneous Candidiasis       0.00      0.00      0.00        10\n",
      "                                     Cutaneous T-cell Lymphoma       0.00      0.00      0.00         1\n",
      "                                      Cyclic Vomiting Syndrome       0.00      0.00      0.00         5\n",
      "                                                      Cyclitis       0.00      0.00      0.00         1\n",
      "                                           Cyclothymic Disorde       0.00      0.00      0.00         1\n",
      "                                               Cystic Fibrosis       1.00      0.29      0.44         7\n",
      "                                                      Dandruff       0.00      0.00      0.00         2\n",
      "                                           Deep Neck Infection       0.00      0.00      0.00         3\n",
      "                                          Deep Vein Thrombosis       0.89      0.67      0.76        24\n",
      "Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery       0.00      0.00      0.00         3\n",
      "                             Deep Vein Thrombosis, First Event       0.00      0.00      0.00         2\n",
      "                             Deep Vein Thrombosis, Prophylaxis       0.00      0.00      0.00         6\n",
      "                         Deep Vein Thrombosis, Recurrent Event       0.00      0.00      0.00         2\n",
      "                                                      Dementia       0.00      0.00      0.00         1\n",
      "                                                Dental Abscess       0.50      0.09      0.15        23\n",
      "                                                    Depression       0.52      0.77      0.62      3095\n",
      "                                              Dercum's Disease       0.00      0.00      0.00         3\n",
      "                                                    Dermatitis       0.50      0.11      0.19        35\n",
      "                                           Dermatologic Lesion       1.00      0.33      0.50         6\n",
      "                                      Dermatological Disorders       1.00      0.15      0.27        13\n",
      "                                               Dermatomyositis       0.00      0.00      0.00         1\n",
      "                                               Dermatophytosis       0.00      0.00      0.00         1\n",
      "                                            Diabetes Insipidus       1.00      0.14      0.25         7\n",
      "                                              Diabetes, Type 1       0.68      0.29      0.41        45\n",
      "                                              Diabetes, Type 2       0.76      0.87      0.81       808\n",
      "                                       Diabetic Kidney Disease       0.00      0.00      0.00         5\n",
      "                                        Diabetic Macular Edema       1.00      0.67      0.80         3\n",
      "                                Diabetic Peripheral Neuropathy       0.62      0.09      0.16        54\n",
      "                                   Diagnosis and Investigation       0.00      0.00      0.00         7\n",
      "                                                   Diaper Rash       0.60      0.50      0.55         6\n",
      "                                                      Diarrhea       1.00      0.33      0.50        69\n",
      "                                               Diarrhea, Acute       0.00      0.00      0.00         4\n",
      "                                             Diarrhea, Chronic       1.00      0.38      0.55        24\n",
      "                                 Dietary Fiber Supplementation       0.00      0.00      0.00         3\n",
      "                                       Dietary Supplementation       1.00      0.09      0.17        22\n",
      "                                 Dissociative Identity Disorde       0.00      0.00      0.00         1\n",
      "                                                Diverticulitis       0.79      0.79      0.79        43\n",
      "                                               Dry Eye Disease       0.71      0.78      0.74        54\n",
      "                                                      Dry Skin       0.80      0.18      0.30        22\n",
      "                                              Dumping Syndrome       0.00      0.00      0.00         2\n",
      "                                                 Duodenal Ulce       0.00      0.00      0.00         7\n",
      "                                       Dupuytren's contracture       1.00      1.00      1.00         1\n",
      "                                                  Dysautonomia       1.00      0.20      0.33         5\n",
      "                                                   Dyspareunia       1.00      0.40      0.57         5\n",
      "                                                      Dystonia       0.00      0.00      0.00         4\n",
      "                                                       Dysuria       1.00      0.11      0.19        28\n",
      "                                             Ear Wax Impaction       0.00      0.00      0.00         3\n",
      "                                                        Eczema       0.57      0.58      0.57        52\n",
      "                                                         Edema       0.79      0.56      0.66        41\n",
      "                                                  Ehrlichiosis       0.00      0.00      0.00         1\n",
      "                                       Emergency Contraception       0.90      0.95      0.92       827\n",
      "                                             Endometrial Cance       0.00      0.00      0.00         3\n",
      "                                       Endometrial Hyperplasia       0.00      0.00      0.00         3\n",
      "                                                 Endometriosis       0.70      0.40      0.51       192\n",
      "                                                 Enterocolitis       0.00      0.00      0.00         1\n",
      "                                      Eosinophilic Esophagitis       1.00      1.00      1.00         1\n",
      "                            Epididymitis, Sexually Transmitted       0.00      0.00      0.00         1\n",
      "                                                      Epilepsy       0.83      0.40      0.54       120\n",
      "                                          Erectile Dysfunction       0.78      0.84      0.81       381\n",
      "                                           Erosive Esophagitis       0.00      0.00      0.00        20\n",
      "                    Esophageal Variceal Hemorrhage Prophylaxis       0.00      0.00      0.00         1\n",
      "                                                 Expectoration       1.00      0.50      0.67         2\n",
      "                                       Extrapyramidal Reaction       0.00      0.00      0.00        10\n",
      "                                                   Eye Redness       0.86      0.40      0.55        15\n",
      "                                           Eye Redness/Itching       1.00      0.20      0.33        10\n",
      "                                         Eyelash Hypotrichosis       0.00      0.00      0.00         3\n",
      "                                                          GERD       0.67      0.75      0.71       246\n",
      "                                           Gallbladder Disease       0.00      0.00      0.00         2\n",
      "                                                           Gas       0.75      0.43      0.55         7\n",
      "                           Gastric Ulcer Maintenance Treatment       0.00      0.00      0.00         3\n",
      "                                          Gastritis/Duodenitis       0.00      0.00      0.00         3\n",
      "                                               Gastroenteritis       0.00      0.00      0.00        10\n",
      "                              Gastrointestinal Decontamination       0.00      0.00      0.00         4\n",
      "                                   Gastrointestinal Hemorrhage       0.00      0.00      0.00         2\n",
      "                                  Gastrointestinal Stromal Tum       0.00      0.00      0.00         4\n",
      "                                                 Gastroparesis       1.00      0.29      0.44        14\n",
      "                                              Gender Dysphoria       0.00      0.00      0.00         1\n",
      "                                   Generalized Anxiety Disorde       0.60      0.06      0.11       378\n",
      "                                      Giant Cell Tumor of Bone       0.00      0.00      0.00         1\n",
      "                                                    Giardiasis       1.00      0.29      0.44         7\n",
      "                                                    Gingivitis       1.00      0.20      0.33         5\n",
      "                                                      Glaucoma       0.00      0.00      0.00         9\n",
      "                                          Glaucoma, Open Angle       1.00      0.39      0.56        18\n",
      "                                            Glioblastoma Multi       0.00      0.00      0.00         1\n",
      "                                       Glioblastoma Multiforme       0.00      0.00      0.00         2\n",
      "                                       Gonadotropin Inhibition       0.00      0.00      0.00         1\n",
      "                           Gonococcal Infection, Uncomplicated       0.00      0.00      0.00         2\n",
      "                                                          Gout       0.95      0.81      0.88        26\n",
      "                                                   Gout, Acute       0.67      0.77      0.72        56\n",
      "                                               Gouty Arthritis       0.00      0.00      0.00         9\n",
      "                                                 HIV Infection       0.89      0.85      0.87       202\n",
      "                                           Hashimoto's disease       0.82      0.32      0.46        71\n",
      "                                                   Head Injury       0.00      0.00      0.00         1\n",
      "                                                     Head Lice       1.00      0.94      0.97        32\n",
      "                                           Head and Neck Cance       1.00      1.00      1.00         1\n",
      "                                                      Headache       0.74      0.53      0.62       153\n",
      "                                                  Heart Attack       0.67      0.42      0.52        19\n",
      "                                                 Heart Failure       0.43      0.22      0.29        27\n",
      "                                 Helicobacter Pylori Infection       0.88      0.73      0.79        77\n",
      "                                                  Hemophilia A       0.00      0.00      0.00         1\n",
      "                                                  Hemophilia B       0.00      0.00      0.00         1\n",
      "                                                   Hemorrhoids       0.89      0.53      0.67        30\n",
      "                          Hemorrhoids (pramoxine / zinc oxide)       0.00      0.00      0.00         1\n",
      "                                        Hepatic Encephalopathy       1.00      0.38      0.55         8\n",
      "                                                   Hepatitis B       1.00      0.14      0.25         7\n",
      "                                                   Hepatitis C       0.91      0.90      0.91       245\n",
      "                                      Hepatocellular Carcinoma       1.00      0.50      0.67         2\n",
      "                                        Herbal Supplementation       0.00      0.00      0.00         5\n",
      "                                         Hereditary Angioedema       1.00      0.86      0.92         7\n",
      "                                                Herpes Simplex       0.89      0.71      0.79       129\n",
      "                            Herpes Simplex Dendritic Keratitis       0.00      0.00      0.00         1\n",
      "            Herpes Simplex, Mucocutaneous/Immunocompetent Host       0.00      0.00      0.00         6\n",
      "          Herpes Simplex, Mucocutaneous/Immunocompromised Host       0.00      0.00      0.00         1\n",
      "                                   Herpes Simplex, Suppression       0.51      0.61      0.56        44\n",
      "                                                  Herpes Zoste       1.00      0.10      0.18        10\n",
      "                                    Herpes Zoster, Prophylaxis       0.00      0.00      0.00         1\n",
      "                                                       Hiccups       0.67      0.67      0.67         6\n",
      "                                      Hidradenitis Suppurativa       0.00      0.00      0.00         3\n",
      "                                           High Blood Pressure       0.63      0.83      0.72       783\n",
      "                                              High Cholesterol       0.78      0.77      0.77       206\n",
      "                       High Cholesterol, Familial Heterozygous       0.00      0.00      0.00        18\n",
      "                         High Cholesterol, Familial Homozygous       0.00      0.00      0.00         3\n",
      "                                                     Hirsutism       0.91      0.67      0.77        48\n",
      "                                                Histoplasmosis       0.00      0.00      0.00         1\n",
      "                                                   Hot Flashes       0.57      0.75      0.65        67\n",
      "                                         Human Papilloma Virus       0.89      0.85      0.87        39\n",
      "                              Human Papillomavirus Prophylaxis       1.00      0.38      0.55         8\n",
      "                                   Hypercalcemia of Malignancy       0.00      0.00      0.00         2\n",
      "                                                 Hyperekplexia       0.00      0.00      0.00         2\n",
      "                                                 Hyperhidrosis       0.87      0.95      0.91       240\n",
      "                                                  Hyperkalemia       1.00      1.00      1.00         1\n",
      "                                          Hyperlipoproteinemia       1.00      0.50      0.67         2\n",
      "                   Hyperlipoproteinemia Type IIa, Elevated LDL       0.00      0.00      0.00         5\n",
      "                                             Hyperphosphatemia       0.00      0.00      0.00         1\n",
      "                            Hyperphosphatemia of Renal Failure       1.00      0.40      0.57         5\n",
      "                                            Hyperprolactinemia       0.60      0.43      0.50        14\n",
      "                                                   Hypersomnia       1.00      0.16      0.28        25\n",
      "                                        Hypertensive Emergency       0.00      0.00      0.00         1\n",
      "                                               Hyperthyroidism       0.00      0.00      0.00         3\n",
      "                                          Hypertriglyceridemia       1.00      0.46      0.63        26\n",
      "                              Hypoactive Sexual Desire Disorde       0.00      0.00      0.00         1\n",
      "                                                  Hypocalcemia       1.00      0.33      0.50         3\n",
      "                                               Hypodermoclysis       0.00      0.00      0.00         1\n",
      "                                               Hypoestrogenism       1.00      0.22      0.36         9\n",
      "                                            Hypogonadism, Male       0.93      0.84      0.88       195\n",
      "                                Hypokalemic Periodic Paralysis       0.00      0.00      0.00         1\n",
      "                                                Hypomagnesemia       0.00      0.00      0.00         3\n",
      "                                            Hypoparathyroidism       1.00      0.50      0.67         2\n",
      "                                                   Hypotension       0.00      0.00      0.00         4\n",
      "                         Hypothyroidism, After Thyroid Removal       0.62      0.22      0.32        37\n",
      "                                                 ICU Agitation       0.00      0.00      0.00         2\n",
      "                                                    Ichthyosis       0.00      0.00      0.00         1\n",
      "                           Idiopathic Thrombocytopenic Purpura       0.67      0.29      0.40         7\n",
      "                                             Immunosuppression       0.00      0.00      0.00         1\n",
      "                                                       Impetig       1.00      1.00      1.00         3\n",
      "                                                   Indigestion       1.00      0.05      0.10        20\n",
      "                                         Infection Prophylaxis       0.00      0.00      0.00         5\n",
      "                                    Inflammatory Bowel Disease       1.00      0.22      0.36         9\n",
      "                                       Inflammatory Conditions       0.54      0.13      0.20       103\n",
      "                                                     Influenza       0.83      0.87      0.85       117\n",
      "                                         Influenza Prophylaxis       0.00      0.00      0.00         5\n",
      "                                                      Insomnia       0.64      0.87      0.74      1231\n",
      "                                Insomnia, Stimulant-Associated       0.00      0.00      0.00         3\n",
      "                                   Insulin Resistance Syndrome       0.00      0.00      0.00         8\n",
      "                                     Intermittent Claudication       1.00      0.33      0.50         3\n",
      "                                         Interstitial Cystitis       0.69      0.56      0.62        45\n",
      "                                      Intraabdominal Infection       0.00      0.00      0.00         2\n",
      "                                      Intraocular Hypertension       1.00      0.22      0.36         9\n",
      "                                                        Iritis       1.00      0.33      0.50         3\n",
      "                                        Iron Deficiency Anemia       0.57      0.27      0.36        15\n",
      "                                      Irritable Bowel Syndrome       0.72      0.73      0.72       325\n",
      "                                               Ischemic Stroke       0.00      0.00      0.00         2\n",
      "                                  Ischemic Stroke, Prophylaxis       1.00      0.75      0.86         8\n",
      "                                                       Jet Lag       0.00      0.00      0.00         1\n",
      "                                               Joint Infection       0.00      0.00      0.00         1\n",
      "                                 Juvenile Idiopathic Arthritis       0.00      0.00      0.00         7\n",
      "                                 Juvenile Rheumatoid Arthritis       0.00      0.00      0.00         8\n",
      "                                                     Keratitis       0.00      0.00      0.00         1\n",
      "                                    Keratoconjunctivitis Sicca       0.95      0.73      0.83        26\n",
      "                                                     Keratosis       0.87      0.60      0.71        45\n",
      "                                             Kidney Infections       0.50      0.19      0.27        32\n",
      "                                               Labor Induction       1.00      0.60      0.75         5\n",
      "                                                    Labor Pain       1.00      0.20      0.33         5\n",
      "                                        Lactation Augmentation       0.00      0.00      0.00         4\n",
      "                                           Lactose Intolerance       0.50      1.00      0.67         2\n",
      "                                  Left Ventricular Dysfunction       0.00      0.00      0.00         7\n",
      "                                       Lennox-Gastaut Syndrome       0.00      0.00      0.00         5\n",
      "                                                      Leukemia       1.00      1.00      1.00         1\n",
      "                                                 Lichen Planus       0.00      0.00      0.00         3\n",
      "                                              Lichen Sclerosus       0.00      0.00      0.00         2\n",
      "                                              Light Anesthesia       1.00      0.15      0.27        13\n",
      "                                                Light Sedation       1.00      0.04      0.08        23\n",
      "                                                 Lipodystrophy       1.00      0.67      0.80         3\n",
      "                              Liver Magnetic Resonance Imaging       1.00      0.50      0.67         2\n",
      "                                              Local Anesthesia       1.00      0.33      0.50         3\n",
      "                                                  Lyme Disease       0.75      0.60      0.67        10\n",
      "                      Lyme Disease, Erythema Chronicum Migrans       0.00      0.00      0.00         1\n",
      "                                      Lyme Disease, Neurologic       1.00      0.25      0.40         4\n",
      "                                           Lymphocytic Colitis       0.00      0.00      0.00         2\n",
      "                                                      Lymphoma       0.00      0.00      0.00         3\n",
      "                                          Macular Degeneration       0.78      0.70      0.74        10\n",
      "                                                 Macular Edema       0.00      0.00      0.00         3\n",
      "                                      Major Depressive Disorde       0.62      0.10      0.17       524\n",
      "                                                       Malaria       1.00      0.14      0.25         7\n",
      "                                            Malaria Prevention       0.92      0.79      0.85        14\n",
      "                                                         Mania       0.00      0.00      0.00        20\n",
      "                                          Mantle Cell Lymphoma       0.00      0.00      0.00         2\n",
      "                                                      Melanoma       1.00      1.00      1.00         1\n",
      "                                          Melanoma, Metastatic       1.00      0.67      0.80         3\n",
      "                                                       Melasma       1.00      0.57      0.73        28\n",
      "                                             Meniere's Disease       1.00      0.12      0.22         8\n",
      "                          Meningococcal Meningitis Prophylaxis       1.00      1.00      1.00         1\n",
      "                                          Menopausal Disorders       1.00      0.25      0.40         4\n",
      "                                                   Menorrhagia       0.62      0.31      0.42        16\n",
      "                                           Menstrual Disorders       0.67      0.02      0.03       127\n",
      "         Methicillin-Resistant Staphylococcus Aureus Infection       0.80      0.50      0.62         8\n",
      "                                                      Migraine       0.66      0.81      0.73       583\n",
      "                                           Migraine Prevention       0.70      0.71      0.71       454\n",
      "                                     Mild Cognitive Impairment       0.00      0.00      0.00         3\n",
      "                                         Mitral Valve Prolapse       1.00      0.22      0.36         9\n",
      "                               Mixed Connective Tissue Disease       0.00      0.00      0.00         1\n",
      "                                                 Mononucleosis       0.00      0.00      0.00         1\n",
      "                                               Motion Sickness       0.81      0.85      0.83        72\n",
      "                         Mountain Sickness / Altitude Sickness       1.00      0.75      0.86         4\n",
      "                                                     Mucositis       0.00      0.00      0.00         5\n",
      "                                              Multiple Myeloma       0.60      1.00      0.75         3\n",
      "                                            Multiple Sclerosis       0.88      0.89      0.88       215\n",
      "                                                   Muscle Pain       1.00      0.03      0.06        31\n",
      "                                                  Muscle Spasm       0.65      0.68      0.66       387\n",
      "                                             Myasthenia Gravis       0.71      0.77      0.74        13\n",
      "                 Mycobacterium avium-intracellulare, Treatment       1.00      0.25      0.40         4\n",
      "                                          Mycoplasma Pneumonia       0.00      0.00      0.00         2\n",
      "                                      Myelodysplastic Syndrome       1.00      0.17      0.29         6\n",
      "                                                 Myelofibrosis       0.00      0.00      0.00         1\n",
      "                                  Myeloproliferative Disorders       0.00      0.00      0.00         1\n",
      "                                            Myotonia Congenita       0.00      0.00      0.00         1\n",
      "                                    NSAID-Induced Gastric Ulce       0.00      0.00      0.00         3\n",
      "                                                    Narcolepsy       0.70      0.63      0.66       152\n",
      "                       Nasal Carriage of Staphylococcus aureus       0.00      0.00      0.00         1\n",
      "                                              Nasal Congestion       0.69      0.47      0.56       100\n",
      "                                                  Nasal Polyps       0.00      0.00      0.00         5\n",
      "                   Nausea (phosphorated carbohydrate solution)       0.00      0.00      0.00         1\n",
      "                                               Nausea/Vomiting       0.63      0.67      0.65       266\n",
      "                                  Nausea/Vomiting of Pregnancy       0.96      0.66      0.78        38\n",
      "                         Nausea/Vomiting, Chemotherapy Induced       0.86      0.40      0.55        15\n",
      "                                Nausea/Vomiting, Postoperative       0.00      0.00      0.00         6\n",
      "                                                     Neck Pain       0.00      0.00      0.00         2\n",
      "                                            Nephrotic Syndrome       0.00      0.00      0.00         1\n",
      "                                                     Neuralgia       0.50      0.03      0.06        31\n",
      "                                              Neuropathic Pain       0.75      0.12      0.21        96\n",
      "                                                   Neutropenia       0.00      0.00      0.00         1\n",
      "                      Neutropenia Associated with Chemotherapy       1.00      0.45      0.62        11\n",
      "                                 New Daily Persistent Headache       1.00      0.50      0.67         2\n",
      "                                                 Night Terrors       0.00      0.00      0.00         6\n",
      "                                                    Nightmares       0.00      0.00      0.00         7\n",
      "                                          Nocturnal Leg Cramps       1.00      0.12      0.22         8\n",
      "                                        Non-Hodgkin's Lymphoma       0.80      0.80      0.80         5\n",
      "                                     Non-Small Cell Lung Cance       0.76      0.85      0.80        40\n",
      "                                         Noninfectious Colitis       0.00      0.00      0.00         5\n",
      "                                      Nonoccupational Exposure       0.00      0.00      0.00         1\n",
      "                                             Not Listed / Othe       0.00      0.00      0.00       153\n",
      "                                                       Obesity       0.63      0.66      0.64      1189\n",
      "                                  Obsessive Compulsive Disorde       0.64      0.66      0.65       173\n",
      "                     Obstructive Sleep Apnea/Hypopnea Syndrome       0.90      0.24      0.38        37\n",
      "                                           Occipital Neuralgia       0.00      0.00      0.00         4\n",
      "                                         Occupational Exposure       0.00      0.00      0.00         2\n",
      "                                                  Oligospermia       0.00      0.00      0.00         2\n",
      "                                     Onychomycosis, Fingernail       0.00      0.00      0.00         7\n",
      "                                        Onychomycosis, Toenail       0.76      0.90      0.83       137\n",
      "                                                  Oophorectomy       0.00      0.00      0.00         3\n",
      "                                            Ophthalmic Surgery       1.00      0.67      0.80         3\n",
      "                                                Opiate Adjunct       0.00      0.00      0.00         2\n",
      "                                             Opiate Dependence       0.87      0.89      0.88       398\n",
      "                                             Opiate Withdrawal       0.69      0.56      0.62       107\n",
      "                                               Opioid Overdose       0.00      0.00      0.00         5\n",
      "                                   Opioid-Induced Constipation       0.33      0.06      0.10        18\n",
      "                                  Oppositional Defiant Disorde       0.00      0.00      0.00         1\n",
      "                                                   Oral Thrush       1.00      0.25      0.40         4\n",
      "                                    Oral and Dental Conditions       0.00      0.00      0.00         1\n",
      "                       Organ Transplant, Rejection Prophylaxis       0.69      0.75      0.72        12\n",
      "                          Organ Transplant, Rejection Reversal       1.00      1.00      1.00         1\n",
      "                                                Osteoarthritis       0.65      0.67      0.66       387\n",
      "                   Osteolytic Bone Lesions of Multiple Myeloma       0.00      0.00      0.00         4\n",
      "                    Osteolytic Bone Metastases of Solid Tumors       1.00      0.33      0.50         3\n",
      "                                                  Osteoporosis       0.80      0.80      0.80        86\n",
      "                                                Otitis Externa       0.00      0.00      0.00        11\n",
      "                                                  Otitis Media       0.41      0.51      0.45        55\n",
      "                                                 Ovarian Cance       1.00      1.00      1.00         1\n",
      "                                                 Ovarian Cysts       0.00      0.00      0.00        55\n",
      "                                             Overactive Bladde       0.67      0.71      0.69       234\n",
      "                                           Ovulation Induction       0.00      0.00      0.00         8\n",
      "                                               Paget's Disease       0.00      0.00      0.00         2\n",
      "                                                          Pain       0.52      0.84      0.64      2100\n",
      "                                                     Pain/Feve       0.00      0.00      0.00         1\n",
      "                                              Pancreatic Cance       0.00      0.00      0.00         1\n",
      "                               Pancreatic Exocrine Dysfunction       0.00      0.00      0.00         7\n",
      "                                                 Panic Disorde       0.50      0.32      0.39       469\n",
      "                                              Paranoid Disorde       0.00      0.00      0.00        10\n",
      "                                           Parkinson's Disease       1.00      0.26      0.41        50\n",
      "                                                  Parkinsonism       0.00      0.00      0.00         1\n",
      "                                                            Pe       0.00      0.00      0.00         4\n",
      "                           Pediatric Growth Hormone Deficiency       1.00      0.50      0.67         4\n",
      "                                   Pelvic Inflammatory Disease       0.00      0.00      0.00         4\n",
      "                                                    Pemphigoid       0.00      0.00      0.00         1\n",
      "                                                     Pemphigus       0.00      0.00      0.00         1\n",
      "                                                   Peptic Ulce       0.00      0.00      0.00         5\n",
      "                            Percutaneous Coronary Intervention       0.00      0.00      0.00         3\n",
      "                                           Performance Anxiety       0.00      0.00      0.00         2\n",
      "                                       Perimenopausal Symptoms       0.00      0.00      0.00        15\n",
      "                                                   Period Pain       0.93      0.29      0.44        48\n",
      "                                Periodic Limb Movement Disorde       1.00      0.06      0.11        17\n",
      "                                                 Periodontitis       0.00      0.00      0.00         2\n",
      "                                           Perioral Dermatitis       0.00      0.00      0.00         3\n",
      "                                   Peripheral Arterial Disease       0.00      0.00      0.00         1\n",
      "                                         Peripheral Neuropathy       0.60      0.25      0.35        60\n",
      "                                                   Peritonitis       0.00      0.00      0.00         3\n",
      "                                 Persistent Depressive Disorde       0.00      0.00      0.00         3\n",
      "                                                     Pertussis       0.00      0.00      0.00         1\n",
      "                                         Pertussis Prophylaxis       0.00      0.00      0.00         1\n",
      "                                                   Pharyngitis       0.00      0.00      0.00         2\n",
      "                                        Photoaging of the Skin       0.00      0.00      0.00         8\n",
      "                   Pinworm Infection (Enterobius vermicularis)       1.00      0.33      0.50         6\n",
      "                                      Pityriasis rubra pilaris       1.00      1.00      1.00         1\n",
      "                                              Plaque Psoriasis       0.70      0.59      0.64        98\n",
      "                               Platelet Aggregation Inhibition       1.00      0.50      0.67         2\n",
      "                              Pneumococcal Disease Prophylaxis       1.00      0.09      0.17        11\n",
      "                                                     Pneumonia       0.68      0.58      0.63        88\n",
      "                                     Polycystic Ovary Syndrome       0.76      0.33      0.46        78\n",
      "                                             Polycythemia Vera       0.00      0.00      0.00         1\n",
      "                                  Polymyositis/Dermatomyositis       0.00      0.00      0.00         2\n",
      "                                 Post Traumatic Stress Disorde       0.72      0.19      0.31       118\n",
      "                                 Post-Cholecystectomy Diarrhea       0.00      0.00      0.00         2\n",
      "                                        Postherpetic Neuralgia       0.71      0.12      0.20        43\n",
      "                                       Postmenopausal Symptoms       0.87      0.43      0.58       136\n",
      "                  Postoperative Increased Intraocular Pressure       0.00      0.00      0.00         1\n",
      "                             Postoperative Ocular Inflammation       0.50      0.25      0.33         8\n",
      "                                            Postoperative Pain       0.00      0.00      0.00        13\n",
      "                                         Postpartum Depression       1.00      0.13      0.24        30\n",
      "                     Postural Orthostatic Tachycardia Syndrome       0.71      0.50      0.59        10\n",
      "                                      Pre-Exposure Prophylaxis       0.00      0.00      0.00         1\n",
      "                                            Precocious Puberty       1.00      0.67      0.80         6\n",
      "                                         Premature Ejaculation       0.00      0.00      0.00         1\n",
      "                                                 Premature Lab       0.93      0.72      0.81        36\n",
      "                         Premature Ventricular Depolarizations       0.00      0.00      0.00         2\n",
      "                                Premenstrual Dysphoric Disorde       0.70      0.38      0.49        98\n",
      "                                         Premenstrual Syndrome       1.00      0.14      0.25         7\n",
      "                               Prevention of Bladder infection       1.00      0.22      0.36        18\n",
      "                          Prevention of Cardiovascular Disease       0.00      0.00      0.00         3\n",
      "                                   Prevention of Dental Caries       0.00      0.00      0.00         2\n",
      "                                     Prevention of Hypokalemia       0.00      0.00      0.00         1\n",
      "                                    Prevention of Osteoporosis       0.00      0.00      0.00        11\n",
      "          Prevention of Thromboembolism in Atrial Fibrillation       0.73      0.80      0.76        44\n",
      "                                    Primary Hyperaldosteronism       0.00      0.00      0.00         1\n",
      "                             Primary Immunodeficiency Syndrome       1.00      0.17      0.29        12\n",
      "                                    Primary Nocturnal Enuresis       1.00      0.33      0.50         3\n",
      "                                       Primary Ovarian Failure       0.00      0.00      0.00         4\n",
      "                                    Progesterone Insufficiency       0.00      0.00      0.00         3\n",
      "                                                Prostate Cance       0.78      0.77      0.77        47\n",
      "                                                   Prostatitis       0.87      0.54      0.67        24\n",
      "                                                      Pruritus       0.75      0.18      0.29        17\n",
      "                                           Pseudobulbar Affect       1.00      0.43      0.60         7\n",
      "                                           Pseudotumor Cerebri       0.87      0.71      0.78        28\n",
      "                                                     Psoriasis       0.70      0.79      0.74       198\n",
      "                                           Psoriatic Arthritis       0.77      0.21      0.34       112\n",
      "                                                     Psychosis       1.00      0.20      0.33        25\n",
      "                                            Pudendal Neuralgia       0.00      0.00      0.00         1\n",
      "                                               Pulmonary Edema       0.00      0.00      0.00         1\n",
      "                                            Pulmonary Embolism       0.78      0.70      0.74        20\n",
      "                               Pulmonary Embolism, First Event       0.00      0.00      0.00         2\n",
      "                                        Pulmonary Hypertension       1.00      0.31      0.47        26\n",
      "                                            Pupillary Dilation       1.00      0.50      0.67         2\n",
      "                       Radionuclide Myocardial Perfusion Study       0.00      0.00      0.00         1\n",
      "                                                 Rat-bite Feve       0.00      0.00      0.00         1\n",
      "                                            Raynaud's Syndrome       1.00      0.15      0.27        13\n",
      "                         Reflex Sympathetic Dystrophy Syndrome       1.00      0.08      0.14        13\n",
      "                                          Renal Cell Carcinoma       0.68      0.93      0.79        30\n",
      "                                        Renal Tubular Acidosis       0.00      0.00      0.00         2\n",
      "                                        Restless Legs Syndrome       0.79      0.82      0.81       240\n",
      "                  Reversal of Nondepolarizing Muscle Relaxants       0.00      0.00      0.00         1\n",
      "                                   Reversal of Opioid Sedation       1.00      0.25      0.40         4\n",
      "                                          Rheumatoid Arthritis       0.63      0.69      0.66       320\n",
      "                                                      Rhinitis       1.00      0.10      0.18        31\n",
      "                                                    Rhinorrhea       0.00      0.00      0.00         3\n",
      "                                                       Rosacea       0.88      0.73      0.80       175\n",
      "                                    Salmonella Gastroenteritis       0.00      0.00      0.00         2\n",
      "                                                   Sarcoidosis       0.00      0.00      0.00         4\n",
      "                                                       Scabies       1.00      0.50      0.67         2\n",
      "                                                Schilling Test       0.00      0.00      0.00         1\n",
      "                                       Schizoaffective Disorde       0.71      0.13      0.23       127\n",
      "                                                 Schizophrenia       0.66      0.47      0.55       195\n",
      "                                           Schnitzler Syndrome       1.00      0.50      0.67         2\n",
      "                                                      Sciatica       0.55      0.15      0.24        40\n",
      "                                    Seasonal Affective Disorde       0.00      0.00      0.00         3\n",
      "                              Seasonal Allergic Conjunctivitis       0.83      0.48      0.61        21\n",
      "                                         Seborrheic Dermatitis       1.00      0.10      0.18        10\n",
      "                                 Secondary Hyperparathyroidism       1.00      0.33      0.50         3\n",
      "                                                      Sedation       0.00      0.00      0.00        63\n",
      "                                            Seizure Prevention       1.00      0.03      0.05        71\n",
      "                                                      Seizures       0.65      0.78      0.71       176\n",
      "                              Sexual Dysfunction, SSRI Induced       0.00      0.00      0.00        29\n",
      "                                      Shift Work Sleep Disorde       1.00      0.33      0.50        24\n",
      "                                                Sinus Symptoms       0.00      0.00      0.00        21\n",
      "                                                     Sinusitis       0.64      0.71      0.67       289\n",
      "                                            Sjogren's Syndrome       0.50      0.11      0.18        18\n",
      "                                                    Skin Cance       0.00      0.00      0.00         4\n",
      "                               Skin Disinfection, Preoperative       0.00      0.00      0.00         4\n",
      "                                                     Skin Rash       0.00      0.00      0.00         3\n",
      "                                  Skin and Structure Infection       1.00      0.11      0.19        19\n",
      "                                 Skin or Soft Tissue Infection       0.58      0.20      0.29        56\n",
      "                             Small Bowel or Pancreatic Fistula       1.00      1.00      1.00         1\n",
      "                                             Smoking Cessation       0.91      0.95      0.93       660\n",
      "                                        Social Anxiety Disorde       0.82      0.17      0.29       133\n",
      "                                           Soft Tissue Sarcoma       1.00      0.08      0.14        13\n",
      "                                                         Somat       0.00      0.00      0.00         1\n",
      "                                                   Sore Throat       0.00      0.00      0.00         1\n",
      "                                             Spondyloarthritis       1.00      0.25      0.40         4\n",
      "                                             Spondylolisthesis       0.00      0.00      0.00         1\n",
      "                                       Squamous Cell Carcinoma       0.00      0.00      0.00         1\n",
      "                                            Status Epilepticus       0.00      0.00      0.00         1\n",
      "                    Steroid Responsive Inflammatory Conditions       0.00      0.00      0.00         1\n",
      "                                               Still's Disease       1.00      0.50      0.67         2\n",
      "                                                 Stomach Cance       1.00      1.00      1.00         1\n",
      "                                                  Stomach Ulce       0.00      0.00      0.00        21\n",
      "                                                    Strabismus       0.00      0.00      0.00         1\n",
      "                                                  Strep Throat       0.66      0.43      0.52        49\n",
      "                                       Streptococcal Infection       0.00      0.00      0.00         2\n",
      "                                      Stress Ulcer Prophylaxis       0.00      0.00      0.00         1\n",
      "                                              Strongyloidiasis       0.00      0.00      0.00         1\n",
      "                                       Subarachnoid Hemorrhage       0.00      0.00      0.00         1\n",
      "                                            Submental Fullness       1.00      1.00      1.00         2\n",
      "                                                       Sunburn       0.00      0.00      0.00         1\n",
      "                                  Supraventricular Tachycardia       0.87      0.37      0.52        35\n",
      "                                          Surgical Prophylaxis       0.00      0.00      0.00         7\n",
      "                                                     Swine Flu       0.00      0.00      0.00         7\n",
      "                                                 Syringomyelia       0.00      0.00      0.00         1\n",
      "                                  Systemic Lupus Erythematosus       0.81      0.46      0.59        37\n",
      "                                         Systemic Mastocytosis       1.00      0.50      0.67         2\n",
      "                                            Systemic Sclerosis       0.00      0.00      0.00         2\n",
      "                                               TSH Suppression       0.00      0.00      0.00         6\n",
      "                               Temporomandibular Joint Disorde       0.00      0.00      0.00        10\n",
      "                                                    Tendonitis       0.50      0.05      0.09        21\n",
      "                                               Thrombocythemia       0.00      0.00      0.00         2\n",
      "                             Thromboembolic Stroke Prophylaxis       0.00      0.00      0.00         2\n",
      "                                                 Thyroid Cance       0.00      0.00      0.00         4\n",
      "                                                Thyrotoxicosis       0.00      0.00      0.00         1\n",
      "                                                Tinea Corporis       1.00      0.17      0.29         6\n",
      "                                                  Tinea Cruris       0.00      0.00      0.00         9\n",
      "                                                   Tinea Pedis       0.50      0.08      0.14        12\n",
      "                                                Tinea Versicol       0.75      0.55      0.63        11\n",
      "                                                      Tinnitus       0.20      0.25      0.22         8\n",
      "                                       Tonsillitis/Pharyngitis       0.20      0.09      0.12        23\n",
      "                                          Topical Disinfection       0.00      0.00      0.00         1\n",
      "                                           Tourette's Syndrome       0.76      0.76      0.76        21\n",
      "                                     Transient Ischemic Attack       0.00      0.00      0.00         1\n",
      "                                           Traveler's Diarrhea       0.00      0.00      0.00         2\n",
      "                                                Trichomoniasis       1.00      0.05      0.10        19\n",
      "                                              Trichotillomania       0.00      0.00      0.00         2\n",
      "                                          Trigeminal Neuralgia       0.86      0.63      0.73        51\n",
      "                                          Tuberculosis, Latent       0.00      0.00      0.00         3\n",
      "                           Tympanostomy Tube Placement Surgery       0.00      0.00      0.00         1\n",
      "                                            Ulcerative Colitis       0.66      0.60      0.63        75\n",
      "                                    Ulcerative Colitis, Active       0.73      0.63      0.68        43\n",
      "                               Ulcerative Colitis, Maintenance       0.58      0.58      0.58        12\n",
      "                                          Ulcerative Proctitis       0.00      0.00      0.00         3\n",
      "                                           Underactive Thyroid       0.59      0.71      0.65       118\n",
      "                    Undifferentiated Connective Tissue Disease       1.00      0.14      0.25         7\n",
      "                                         Upper Limb Spasticity       0.00      0.00      0.00         1\n",
      "                             Upper Respiratory Tract Infection       0.78      0.11      0.19        64\n",
      "                                          Urinary Incontinence       0.63      0.19      0.29        64\n",
      "                                             Urinary Retention       0.00      0.00      0.00         1\n",
      "                                       Urinary Tract Infection       0.62      0.74      0.67       431\n",
      "                                          Urinary Tract Stones       0.86      0.88      0.87        43\n",
      "                                                     Urticaria       0.62      0.69      0.65        80\n",
      "                                              Uterine Bleeding       0.00      0.00      0.00         2\n",
      "                                              Uterine Fibroids       1.00      0.18      0.30        17\n",
      "                                                       Uveitis       0.00      0.00      0.00         8\n",
      "                                              Uveitis, Posteri       0.00      0.00      0.00         1\n",
      "                                       Vaginal Yeast Infection       0.77      0.96      0.86       811\n",
      "                                               Varicella-Zoste       0.00      0.00      0.00         2\n",
      "                                        Ventricular Arrhythmia       0.00      0.00      0.00         1\n",
      "                                      Ventricular Fibrillation       0.00      0.00      0.00         2\n",
      "                                       Ventricular Tachycardia       0.00      0.00      0.00         4\n",
      "                                                        Vertig       0.54      0.61      0.57        23\n",
      "                                        Vitamin B12 Deficiency       0.00      0.00      0.00         5\n",
      "                                          Vitamin D Deficiency       1.00      0.17      0.29         6\n",
      "                Vitamin/Mineral Supplementation and Deficiency       0.00      0.00      0.00         7\n",
      "    Vitamin/Mineral Supplementation during Pregnancy/Lactation       0.82      0.56      0.67        25\n",
      "                                                    Vulvodynia       1.00      0.20      0.33        10\n",
      "                                                         Warts       0.00      0.00      0.00         2\n",
      "                                      Wegener's Granulomatosis       0.00      0.00      0.00         1\n",
      "                                                   Weight Loss       0.67      0.67      0.67      1248\n",
      "                                Wolff-Parkinson-White Syndrome       0.00      0.00      0.00         1\n",
      "                                            Women (oxybutynin)       0.00      0.00      0.00         3\n",
      "                                                    Xerostomia       1.00      0.25      0.40         8\n",
      "                                      Yellow Fever Prophylaxis       0.00      0.00      0.00         1\n",
      "                                    Zollinger-Ellison Syndrome       0.00      0.00      0.00         1\n",
      "                                             acial Lipoatrophy       0.00      0.00      0.00         1\n",
      "                                                acial Wrinkles       1.00      0.27      0.43        11\n",
      "                                           actor IX Deficiency       0.00      0.00      0.00         1\n",
      "                        amilial Cold Autoinflammatory Syndrome       1.00      1.00      1.00         1\n",
      "                                                        atigue       0.00      0.00      0.00        21\n",
      "                              cal Segmental Glomerulosclerosis       0.00      0.00      0.00         1\n",
      "                                             emale Infertility       0.70      0.73      0.71        22\n",
      "                                                           eve       1.00      0.75      0.86         4\n",
      "                                   ge (amlodipine / valsartan)       0.67      0.33      0.44         6\n",
      "                                     ibrocystic Breast Disease       0.00      0.00      0.00         1\n",
      "                                                   ibromyalgia       0.69      0.64      0.66       579\n",
      "                                           lic Acid Deficiency       0.00      0.00      0.00         3\n",
      "                                            llicle Stimulation       0.00      0.00      0.00         4\n",
      "                                                m Pain Disorde       0.00      0.00      0.00         2\n",
      "                                                 mance Anxiety       0.86      0.79      0.83        72\n",
      "                                                            me       0.00      0.00      0.00         1\n",
      "                                           min / pioglitazone)       0.00      0.00      0.00         0\n",
      "                                            min / saxagliptin)       0.00      0.00      0.00         4\n",
      "                                            min / sitagliptin)       0.00      0.00      0.00         8\n",
      "                                                          min)       0.50      0.07      0.12        15\n",
      "                                                        mist (       0.00      0.00      0.00         1\n",
      "                                         moterol / mometasone)       0.17      0.14      0.15         7\n",
      "                                                      moterol)       0.50      0.09      0.15        34\n",
      "                                     mulation) (phenylephrine)       0.00      0.00      0.00         3\n",
      "                                       tic (mycophenolic acid)       0.00      0.00      0.00         1\n",
      "                                      von Willebrand's Disease       1.00      0.67      0.80         3\n",
      "                                                   zen Shoulde       0.00      0.00      0.00         7\n",
      "\n",
      "                                                      accuracy                           0.70     53471\n",
      "                                                     macro avg       0.42      0.24      0.28     53471\n",
      "                                                  weighted avg       0.69      0.70      0.67     53471\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[[0 0 0 ... 0 0 0]\n",
      " [0 0 0 ... 0 0 0]\n",
      " [0 0 0 ... 0 0 0]\n",
      " ...\n",
      " [0 0 0 ... 0 0 0]\n",
      " [0 0 0 ... 0 2 0]\n",
      " [0 0 0 ... 0 0 0]]\n"
     ]
    }
   ],
   "source": [
    "from sklearn.pipeline import Pipeline\n",
    "from sklearn.linear_model import SGDClassifier\n",
    "from sklearn.metrics import accuracy_score, classification_report\n",
    "\n",
    "import pickle\n",
    "\n",
    "X_train = training_data['cleaned_review']\n",
    "X_test = test_data['cleaned_review']\n",
    "\n",
    "y_train = training_data['condition']\n",
    "y_test = test_data['condition']\n",
    "\n",
    "pipeline = Pipeline([('vect', vectorizer),\n",
    "                     ('clf', SGDClassifier(loss='modified_huber', max_iter=5, tol=None))])\n",
    "model = pipeline.fit(X_train, y_train)\n",
    "with open('RandomForest.pickle', 'wb') as f:\n",
    "    pickle.dump(model, f)\n",
    "ytest = np.array(y_test)\n",
    "y_hat = model.predict(X_test)\n",
    "print(accuracy_score(y_test, y_hat))\n",
    "print(classification_report(ytest, y_hat ))\n",
    "print(confusion_matrix(ytest, y_hat))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "5bf6044d",
   "metadata": {},
   "outputs": [],
   "source": [
    "result = model.predict([\"unable to sleep properly\", \n",
    "\"pain in my abdomen\", \n",
    "\"severe headache and nasuea\", \n",
    "\"red, itchy and watery eyes\", \n",
    "\"lose motions and stomach upset\",\n",
    "\"looking to reduce smoking and possibly quit\",\n",
    "\"concerned that i am pregnant and don't want to have this baby\", \n",
    "\"pain in my forehead and temples, unable to sleep properly\",\n",
    "\"feeling bloated and like my food comes up to my throat like acid reflux\", \n",
    "\"feeling weak and don't want to eat food. Feeling anxious about exams.\", \n",
    "\"feeling stressed, been unable to sleep and spending too much time worrying\", \n",
    "\"coughing violently and throat is sore\",\n",
    "\"my son is aggressive and violent does not listen, easily distracted\", \n",
    "\"my daughter is having irregular periods and is suffering from pain\",\n",
    "\"i am unable to pass urine easily, i feel pain when going to the toilet\",\n",
    "\"i am feeling tired and anxious.\"])\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "ab7421a7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['Insomnia' 'Pain' 'Headache' 'Conjunctivitis, Allergic' 'Obesity'\n",
      " 'Smoking Cessation' 'Birth Control' 'Pain' 'GERD' 'Diabetes, Type 2'\n",
      " 'Anxiety' 'Cough' 'ADHD' 'Birth Control' 'Constipation' 'Anxiety']\n"
     ]
    }
   ],
   "source": [
    "print(result)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e381afa4",
   "metadata": {},
   "source": [
    "# Testing Prediction"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "e3768149",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pickle\n",
    "\n",
    "with open('RandomForest.pickle', 'rb') as f:\n",
    "    model = pickle.load(f)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "id": "1a996628",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['Diabetes, Type 2'], dtype='<U67')"
      ]
     },
     "execution_count": 51,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result = model.predict(['urinating more often than usual, particularly at night. feeling very thirsty. feeling very tired. unexplained weight loss. itchiness around the genital area, or regular bouts of thrush (a yeast infection) cuts or wounds that heal slowly.'])\n",
    "result"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "88ad143e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['Acne'], dtype='<U67')"
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result = model.predict(['Crusting of skin bumps. Cysts. Papules (small red bumps) Pustules (small red bumps containing white or yellow pus) Redness around the skin eruptions. Scarring of the skin. Whiteheads. Blackheads.'])\n",
    "result"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "5cded252",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['Birth Control'], dtype='<U67')"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "result = model.predict(['Spotting between periods. Breakthrough bleeding, or spotting, refers to when vaginal bleeding occurs between menstrual cycles. Nausea. Breast tenderness. Headaches and migraine. Weight gain. Mood changes. Missed periods. Decreased libido.'])\n",
    "result"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9c642a91",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.11"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
